In conclusion, our findings indicate that RNA-mediated interactions between BAZ2A and TOP2A and KDM1A are implicated in PCa and may prove to be useful for the stratification of PCa risk and treatment in patients. The gene discussed is KDM1A; the disease is posterior cortical atrophy.